Investors are looking for opportunities in the biotech sector, and analysts name the stocks that would be least impacted by potential new tariffs on goods from China, Mexico and Canada. Worldwide Exchange Pick: Amgen David Katz of Matrix Asset Asset Advisors is bullish on biotech Amgen its weight loss drug MariTide moving to a Phase 3 trial in 2025.
President-elect Donald Trump announced Monday on Truth Social that he would impose an additional 10% tariff on imports from China and 25% tariffs on goods from Mexico and Canada when he takes office. "For Walmart about two-thirds of their sourcing comes out of the U.S. market. They may have about 10% from international markets," said Parikh.
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
ソース: CNBC - 🏆 12. / 72 続きを読む »
ソース: CNBC - 🏆 12. / 72 続きを読む »